title: Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.
authors.forename: George J
authors.initials: GJ
authors.lastname: Siegel
authors.forename: Neelima B
authors.initials: NB
authors.lastname: Chauhan
authors.forename: Douglas L
authors.initials: DL
authors.lastname: Feinstein
authors.forename: Ge
authors.initials: G
authors.lastname: Li
authors.forename: Eric B
authors.initials: EB
authors.lastname: Larson
authors.forename: John C S
authors.initials: JC
authors.lastname: Breitner
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Montine
mesh_terms: D000544:Alzheimer Disease / Q000473:pathology* / Q000503:physiopathology / Q000517:prevention & control; D016229:Amyloid beta-Peptides / Q000187:drug effects / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D015536:Down-Regulation / Q000187:drug effects / Q000502:physiology; D004334:Drug Administration Schedule; D042241:Early Diagnosis; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy / Q000378:metabolism; D051379:Mice; D016874:Neurofibrillary Tangles / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D018696:Neuroprotective Agents / Q000494:pharmacology* / Q000627:therapeutic use; D058225:Plaque, Amyloid / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D012107:Research Design
chemical_list: D016229:Amyloid beta-Peptides; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D018696:Neuroprotective Agents